About Imbed Biosciences
Imbed Biosciences is a company based in Madison (United States) founded in 2010.. Imbed Biosciences has raised $22.7 million across 18 funding rounds from investors including NIH, HHS and Niterra Ventures. The company has 35 employees as of December 31, 2022. Imbed Biosciences offers products and services including Surgaflex, PelashieldAM, and Microlyte Matrix. Imbed Biosciences operates in a competitive market with competitors including Adocia, Cresilon, Kane Biotech, Cour Pharma and Alafair Biosciences, among others.
- Headquarter Madison, United States
- Employees 35 as on 31 Dec, 2022
-
Sectors
TechnologyHealthcare Aerospace, Defense & Maritime
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Imbed Biosciences, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$22.7 M (USD)
in 18 rounds
-
Latest Funding Round
$10 M (USD), Debt – Convertible
Jan 08, 2024
-
Investors
NIH
& 6 more
-
Employee Count
35
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Imbed Biosciences
Imbed Biosciences offers a comprehensive portfolio of products and services, including Surgaflex, PelashieldAM, and Microlyte Matrix. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Antimicrobial matrix for surgical wounds management.
Hydrophilic matrix for complex burn wound challenges.
Synthetic skin substitute for chronic wound healing.
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Imbed Biosciences
Imbed Biosciences has successfully raised a total of $22.7M across 18 strategic funding rounds. The most recent funding activity was a Debt – Convertible round of $10 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 18
- Last Round Debt – Convertible — $10.0M
- First Round First Round
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2024 | Amount | Debt – Convertible - Imbed Biosciences | Valuation | Niterra |
|
| Dec, 2023 | Amount | Series B - Imbed Biosciences | Valuation |
investors |
|
| May, 2023 | Amount | Series B - Imbed Biosciences | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Imbed Biosciences
Imbed Biosciences has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH, HHS and Niterra Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Innovative ideas are transformed into reality by Niterra Ventures.
|
Founded Year | Domain | Location | |
|
WISC Partners is engaged in providing expansion and acceleration capital.
|
Founded Year | Domain | Location | |
|
Early-stage entrepreneurs are accelerated through MassChallenge's program.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Imbed Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Imbed Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Imbed Biosciences Comparisons
Competitors of Imbed Biosciences
Imbed Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adocia, Cresilon, Kane Biotech, Cour Pharma and Alafair Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for diabetes and obesity treatment are developed.
|
|
| domain | founded_year | HQ Location |
Developer of hemostatic products for wound care
|
|
| domain | founded_year | HQ Location |
Therapeutic solutions for biofilm prevention and removal are developed.
|
|
| domain | founded_year | HQ Location |
Biotech nanoparticles are developed for immune disease treatments.
|
|
| domain | founded_year | HQ Location |
Biomaterials and devices for internal wound healing are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Imbed Biosciences
Frequently Asked Questions about Imbed Biosciences
When was Imbed Biosciences founded?
Imbed Biosciences was founded in 2010.
Where is Imbed Biosciences located?
Imbed Biosciences is headquartered in Madison, United States. It is registered at Madison, Wisconsin, United States.
Is Imbed Biosciences a funded company?
Imbed Biosciences is a funded company, having raised a total of $22.7M across 18 funding rounds to date. The company's 1st funding round was a Series B of $2.5M, raised on Jun 01, 2010.
How many employees does Imbed Biosciences have?
As of Dec 31, 2022, the latest employee count at Imbed Biosciences is 35.
What does Imbed Biosciences do?
Imbed Biosciences was founded in 2010 and is based in Madison, United States. Focus is placed on the biotechnology sector, where nanotechnology is applied to wound care. Bioactive molecules are embedded into dressings and surgical implants via the Microlyte Matrix platform. Antibacterial, anti-biofilm, and analgesic wound dressings are produced for medical use. Operations center on advancing these technologies for clinical applications.
Who are the top competitors of Imbed Biosciences?
Imbed Biosciences's top competitors include Adocia, Cresilon and Kane Biotech.
What products or services does Imbed Biosciences offer?
Imbed Biosciences offers Surgaflex, PelashieldAM, and Microlyte Matrix.
Who are Imbed Biosciences's investors?
Imbed Biosciences has 7 investors. Key investors include NIH, HHS, Niterra Ventures, Formidable Asset Management, and WISC Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.